Author details

Full Name

Sven Enterlein

Affiliation

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
33836604	Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody.	Proceedings of the National Academy of Sciences of the United States of America	2021
26468532	Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.	Journal of Virology	2016
27044104	Monoclonal antibody therapy for Junin virus infection.	Proceedings of the National Academy of Sciences of the United States of America	2016
26826278	Development of a novel multiplex electrochemiluminescent-based immunoassay for quantification of human serum IgG against 10 Staphylococcus aureus toxins.	Journal of Immunological Methods	2016
26946111	Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4.	Antiviral Res	2016
27160900	Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site.	Cell Rep	2016
27072420	The Iminosugar UV-4 is a Broad Inhibitor of Influenza A and B Viruses ex Vivo and in Mice.	Viruses	2016
25984714	A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue).	Viruses	2015
24190508	Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA.	Arch Virol	2014
25256396	Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.	Viruses	2014
23582637	The L-VP35 and L-L interaction domains reside in the amino terminus of the Ebola virus L protein and are potential targets for antivirals.	Virology	2013
23001720	Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae.	Arch Virol	2013
23358612	Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae.	Arch Virol	2013
21858822	Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles.	Journal of Pharmaceutical Sciences	2011
20211898	Antiviral activity of a small-molecule inhibitor of filovirus infection.	Antimicrobial Agents and Chemotherapy	2010
20702783	Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.	Molecular and Cellular Proteomics	2010
19225002	The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.	Journal of Virology	2009
19523489	Development of a broad-spectrum antiviral with activity against Ebola virus.	Antiviral Research	2009
17904180	Establishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.	Virology	2008
16379005	Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30.	J Virol	2006
16477309	Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus.	PLoS Pathog	2006
16495261	VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice.	Antimicrob Agents Chemother	2006
16051858	The Ebola virus genomic replication promoter is bipartite and follows the rule of six.	Journal of Virology	2005
15661171	A reconstituted replication and transcription system for Ebola virus Reston and comparison with Ebola virus Zaire.	Virology	2005